In conclusion, SAA demonstrates high diagnostic efficacy for the diagnosis of neonatal sepsis, providing clinicians with an effective diagnostic tool that aids in the early detection of sepsis, formulation of appropriate treatment plans, and consequently, improvement of treatment outcomes and survival rates associated with sepsis. The gene discussed is SAA1; the disease is Neonatal sepsis.